Current data shows 40% of US adults live with obesity, more than 100 million potential users, yet demand for these medications remains high despite substantial costs
According to a report, about 55% of commercial employers currently cover GLP-1s for obesity, but 15% of those have dropped coverage due to unsustainable costs
We are reshaping the MIPS quality measure inventory to focus on different high-priority measures, as determined by the current administration, fewer process measures, and more outcome-based measures that align across quality reporting programs [432] (for example, XXX) and payers
Do not self-administer unless specifically instructed by your healthcare provider
The violet pigment can cool down excess warmth in any head of hair, including a silvery mane
"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications"